CompareMarketResearchRequest a sample
Home / Healthcare / Pharmaceutical Excipients

Healthcare · Market report

Pharmaceutical Excipients Market Size, Share and Forecast 2026-2036

The global pharmaceutical excipients market is worth USD 10.1 bn in 2026 and is forecast to reach USD 19.0 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Organic chemicals is the largest by product segment.

USD 10.1 bnMarket size 2026
USD 19.0 bnForecast 2036
6.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global pharmaceutical excipients market is worth USD 10.1 bn in 2026 and is forecast to reach USD 19.0 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Organic chemicals is the largest by product segment.

ScopeInactive ingredients used in finished drugs: binders, fillers, disintegrants, coatings, solvents, lubricants, preservatives and bioavailability enhancers, for tablets, capsules, injectables and topicals.
IndustryHealthcare
Value 2025USD 9.5 bn
Value 2026USD 10.1 bn
Value 2036USD 19.0 bn
CAGR 2026-20366.5%
Volume 20262,952 thousand tonnes
Volume 20365,017 thousand tonnes
Average price 2026USD 3,427 per tonne
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Pharmaceutical Excipients market size and forecast, 2026-2036

Exhibit 1The global pharmaceutical excipients market is forecast to grow from USD 10.1 bn in 2026 to USD 19.0 bn by 2036, a rise of 88%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 6.5%
Pharmaceutical Excipients market value, 2025 to 2036Market value by year. 2025: USD 9.5 bn; 2026: USD 10.1 bn; 2027: USD 10.8 bn; 2028: USD 11.5 bn; 2029: USD 12.2 bn; 2030: USD 13.0 bn; 2031: USD 13.9 bn; 2032: USD 14.8 bn; 2033: USD 15.7 bn; 2034: USD 16.7 bn; 2035: USD 17.8 bn; 2036: USD 19.0 bn. Compound annual growth rate 2026 to 2036: 6.5%.202510.1 bn202613.9 bn203119.0 bn20366.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 10.1 bn
2027USD 10.8 bn
2028USD 11.5 bn
2029USD 12.2 bn
2030USD 13.0 bn
2031USD 13.9 bn
2032USD 14.8 bn
2033USD 15.7 bn
2034USD 16.7 bn
2035USD 17.8 bn
2036USD 19.0 bn

Pharmaceutical Excipients market segmentation

By product

Exhibit 2Organic chemicals is the largest segment by product, with 30.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Pharmaceutical Excipients market share by product, 2026Share of 2026 revenue by product. Organic chemicals: 30.0%; Cellulose and polymers: 26.0%; Sugars and polyols: 16.0%; Oleochemicals and lipids: 12.0%; Inorganic chemicals: 10.0%; Other excipients: 6.0%.Organic chemicals30.0%Cellulose and polymers26.0%Sugars and polyols16.0%Oleochemicals and lipids12.0%Inorganic chemicals10.0%Other excipients6.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Organic chemicals30.0%29.2%USD 3.0 bn6.2%
Cellulose and polymers26.0%27.8%USD 2.6 bn7.2%
Sugars and polyols16.0%14.9%USD 1.6 bn5.7%
Oleochemicals and lipids12.0%13.4%USD 1.2 bn7.7%
Inorganic chemicals10.0%8.9%USD 1.0 bn5.2%
Other excipients6.0%5.8%USD 607 mn6.2%

By function

Exhibit 3Solubilisers and other functions adds the most revenue by function, growing from USD 2.4 bn in 2026 to USD 5.2 bn by 2036Estimated revenue in USD by function, 2026 and 2036 forecast
Pharmaceutical Excipients market by function, 2026 and 2036Revenue by function in 2026 and 2036. Solubilisers and other functions: USD 2.4 bn in 2026, USD 5.2 bn in 2036, change +115%; Fillers and diluents: USD 2.2 bn in 2026, USD 3.8 bn in 2036, change +70%; Disintegrants and lubricants: USD 2.0 bn in 2026, USD 3.6 bn in 2036, change +78%; Binders: USD 1.8 bn in 2026, USD 3.2 bn in 2036, change +78%; Coatings and film formers: USD 1.6 bn in 2026, USD 3.2 bn in 2036, change +95%.20262036 forecastChangeSolubilisers and other functions+115%2.4 bn5.2 bnFillers and diluents+70%2.2 bn3.8 bnDisintegrants and lubricants+78%2.0 bn3.6 bnBinders+78%1.8 bn3.2 bnCoatings and film formers+95%1.6 bn3.2 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Fillers and diluents22.0%19.9%USD 2.2 bn5.4%
Binders18.0%17.1%USD 1.8 bn5.9%
Coatings and film formers16.0%16.7%USD 1.6 bn6.9%
Disintegrants and lubricants20.0%19.0%USD 2.0 bn5.9%
Solubilisers and other functions24.0%27.4%USD 2.4 bn7.9%

By dosage form

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Oral solids56.0%50.0%USD 5.7 bn5.3%
Injectables18.0%23.3%USD 1.8 bn9.3%
Topicals and liquids26.0%26.7%USD 2.6 bn6.8%

By origin

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Synthetic and chemical62.0%58.6%USD 6.3 bn5.9%
Plant-based24.0%26.3%USD 2.4 bn7.5%
Animal-derived8.0%7.1%USD 809 mn5.2%
Mineral4.0%4.0%USD 405 mn6.5%
Fermentation-derived2.0%4.0%USD 202 mn14.1%

By functionality grade

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Compendial grade60.0%56.0%USD 6.1 bn5.8%
High-purity grade24.0%26.0%USD 2.4 bn7.4%
Multifunctional co-processed grade16.0%18.0%USD 1.6 bn7.8%

Top 25 countries for pharmaceutical excipients by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.5% of 2026 revenue and the 25 countries below together hold 95.2%.

Exhibit 4United States is the largest country market at USD 2.7 bn in 2026, and the three largest countries hold 50.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Pharmaceutical Excipients market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.7 bn, 27.0%; China: USD 1.6 bn, 16.0%; Germany: USD 708 mn, 7.0%; India: USD 708 mn, 7.0%; Japan: USD 607 mn, 6.0%; France: USD 506 mn, 5.0%; United Kingdom: USD 405 mn, 4.0%; Italy: USD 354 mn, 3.5%; Switzerland: USD 304 mn, 3.0%; Brazil: USD 304 mn, 3.0%.United States2.7 bn 27.0%China1.6 bn 16.0%Germany708 mn 7.0%India708 mn 7.0%Japan607 mn 6.0%France506 mn 5.0%United Kingdom405 mn 4.0%Italy354 mn 3.5%Switzerland304 mn 3.0%Brazil304 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.7 bn27.0%USD 4.9 bn6.0%
2ChinaUSD 1.6 bn16.0%USD 3.5 bn8.0%
3GermanyUSD 708 mn7.0%USD 1.2 bn5.5%
4IndiaUSD 708 mn7.0%USD 1.7 bn9.0%
5JapanUSD 607 mn6.0%USD 950 mn4.6%
6FranceUSD 506 mn5.0%USD 855 mn5.4%
7United KingdomUSD 405 mn4.0%USD 684 mn5.4%
8ItalyUSD 354 mn3.5%USD 608 mn5.5%
9SwitzerlandUSD 304 mn3.0%USD 551 mn6.1%
10BrazilUSD 304 mn3.0%USD 589 mn6.8%
11SpainUSD 216 mn2.1%USD 405 mn6.5%
12CanadaUSD 179 mn1.8%USD 336 mn6.5%
13NetherlandsUSD 160 mn1.6%USD 300 mn6.5%
14AustraliaUSD 143 mn1.4%USD 268 mn6.5%
15South KoreaUSD 122 mn1.2%USD 230 mn6.5%
16MexicoUSD 98 mn1.0%USD 184 mn6.5%
17TurkeyUSD 87 mn0.9%USD 163 mn6.5%
18RussiaUSD 78 mn0.8%USD 146 mn6.5%
19PolandUSD 67 mn0.7%USD 125 mn6.5%
20BelgiumUSD 58 mn0.6%USD 108 mn6.5%
21SwedenUSD 50 mn0.5%USD 93 mn6.5%
22IndonesiaUSD 39 mn0.4%USD 74 mn6.5%
23TaiwanUSD 35 mn0.3%USD 66 mn6.5%
24IrelandUSD 29 mn0.3%USD 55 mn6.5%
25Saudi ArabiaUSD 26 mn0.3%USD 49 mn6.5%
Rest of worldUSD 485 mn4.8%USD 891 mn6.3%
Exhibit 5United States and China account for 45% of the USD 8.9 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Pharmaceutical Excipients market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 10.1 bn. United States: +USD 2.1 bn; China: +USD 1.9 bn; India: +USD 963 mn; Germany: +USD 507 mn; France: +USD 349 mn; 20 other countries: +USD 2.6 bn; Rest of world: +USD 406 mn. Market value 2036: USD 19.0 bn.Market value 202610.1 bnUnited States+2.1 bnChina+1.9 bnIndia+963 mnGermany+507 mnFrance+349 mn20 other countries+2.6 bnRest of world+406 mnMarket value 203619.0 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • BASF
  • Dow
  • Ashland
  • Roquette
  • IFF
  • Evonik

Group 2: Regional and specialist players

  • Colorcon
  • Merck KGaA
  • DFE Pharma
  • JRS Pharma
  • Croda
  • Lubrizol
  • Shin-Etsu Chemical
  • Meggle
  • Seppic
  • Lotte Fine Chemical

Group 3: Emerging and niche players

  • Gattefosse
  • Signet Chemical Corporation
  • SPI Pharma
  • Sigachi Industries
  • Spectrum Chemical
  • Anhui Sunhere Pharmaceutical Excipients
  • Huzhou Zhanwang Pharmaceutical

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the pharmaceutical excipients market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.

The market is divided by product, by function, by dosage form, by origin, by functionality grade. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the pharmaceutical excipients market?

The global pharmaceutical excipients market is estimated at USD 9.5 bn in 2025 and USD 10.1 bn in 2026.

How fast will the pharmaceutical excipients market grow?

It is forecast to reach USD 19.0 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 8.9 bn.

Which country is the largest market for pharmaceutical excipients?

United States is the largest market by revenue at USD 2.7 bn in 2026, 27.0% of the global total. The three largest countries together hold 50.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.0% a year from 2026 to 2036.

Which pharmaceutical excipients segment is largest?

In the by product split, Organic chemicals is the largest segment with 30.0% of 2026 revenue.

Who are the leading pharmaceutical excipients companies?

Global leaders include BASF, Dow, Ashland, Roquette.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Pharmaceutical Distribution Pharmaceutical Filtration →

All Healthcare markets →

Request a sample